Skip to main content
. Author manuscript; available in PMC: 2018 Jan 29.
Published in final edited form as: Int J Tuberc Lung Dis. 2012 Sep 14;16(11):1538–1543. doi: 10.5588/ijtld.12.0071

Table 4. Effect of NRA on favorable treatment response.

Cohort, n included in model NRA n (%) Conventional DST n (%) Unadjusted OR (95%CI) Adjusted OR (95%CI)*
Entire cohort (n = 1354) 461 (62.6) 363 (58.8) 1.17 (0.94–1.46) 1.13 (0.91–1.41)
Drug-resistant cohort (n = 474) 136 (50.6) 94 (45.9) 1.27 (0.84–1.74) 1.19 (0.83–1.72)
No prior treatment (n = 627) 186 (56.5) 142 (47.7) 1.43 (1.04–1.96) 1.39 (1.01–1.90)
*

Controlling for differences in age and suspected Category I or II failures.

NRA = nitrate reductase assay; DST = drug susceptibility testing; OR = odds ratio; CI = confidence interval.